Instructions TF780K
Instructions TF780KS
Description
Transfection, the introduction of nucleic acid into mammalian cells, is a powerful technique used to study in vivo gene function and regulation. The Cytofect™ Hepatocyte Transfection kit is a plasmid DNA delivery system specifically optimized to deliver DNA into hepatocytes. This kit contains Cytofect-1, Viral Enhancer* and Media for transfection and culturing cells. Viral Enhancer complexes with DNA and Cytofect-1 and escorts the transfection complex to the nucleus. This results in high transfection efficiency and viability for these traditionally hard-to-transfect primary cells.
#Wells / Rxns
96 / 1000
24 / 200
12 / 100
The Kit contains all necessary reagents, media and optimized protocols to carry out successful transfection of primary Hepatocytes with high efficiency (40%) and viability (70%-95%).
Products are for research use only. They are not intended for human, animal, or diagnostic applications. Viral Enhancer (VE) is a replication-deficient, Adenovirus-derived formulation that does not contain replication competent virus. TR1 and VE are manufactured by Targeting Systems.
(Click to Enlarge) Transfection of Rat Hepatocytes with a GFP-expression plasmid using the Cytofect™ Hepatocyte Transfection Kit.
Details
Kit Contents: | Cytofect -1 Viral Enhancer (VE) Antibiotics-Free Growth Medium Transfection Medium |
Designed to improve transfection efficiency and cell viability, Cytofect is a plasmid DNA delivery system containing Cytofect-2, Enhancer and Media for transfecting and culturing cells. The Enhancer is an endosomolytic peptide that complexes with DNA and Cytofect-2, then escorts the transfection complex to the nucleus. The results are high transfection efficiency and viability for traditionally hard-to-transfect cells.
Products
| Product | Size | CAT.# | Price | Quantity |
|---|---|---|---|---|
| Cytofect Hepatocyte Transfection kit (200 x 24-Wells): 200 x 24-Well Rxns | Size: 1 Kit | CAT.#: TF780K | Price: $465.00 | |
| Cytofect Hepatocyte Transfection Sample Kit (25 x 24-Wells): 25 x 24-Well Rxns | Size: 1 Sample Kit | CAT.#: TF780KS | Price: $62.00 |
Related Products
| Product | Size | CAT.# | Price | Quantity |
|---|---|---|---|---|
| Cytofect-1 (CF1): Store at -20°C | Size: 250 ul | CAT.#: 051-250 | Price: $175.00 | |
| Cytofect-1 (CF1): Store at -20°C | Size: 500 ul | CAT.#: 051-500 | Price: $283.00 | |
| Cytofect-2 (CF2) : Store at 4°C | Size: 250 ul | CAT.#: 052-250 | Price: $175.00 | |
| Cytofect-2 (CF2) : Store at 4°C | Size: 500 ul | CAT.#: 052-500 | Price: $283.00 | |
| Peptide Enhancer (PE): Store at 4°C | Size: 250 ul | CAT.#: 053-250 | Price: $141.00 | |
| Peptide Enhancer (PE): Store at 4°C | Size: 500 ul | CAT.#: 053-500 | Price: $236.00 | |
| Viral Enhancer (VE): Store at -20°C | Size: 250 ul | CAT.#: 054-250 | Price: $141.00 | |
| Viral Enhancer (VE): Store at -20°C | Size: 500 ul | CAT.#: 054-500 | Price: $236.00 | |
| Cyyofect Transfection Medium: Cyyofect Transfection Medium | Size: 500 ml | CAT.#: TF56-500 | Price: $54.00 |
Resources/Documents
Citations
Powered by BiozPublications
2016
Sahoo, S., D. Meijles, I. Ghouleh, M. Tandon, E. Cifuentes-Pagano, J. Sembrat, M. Rojas, E. Goncharova and P. Pagano. 2016. MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension. PLoS ONE, dx.doi.org/10.1371/journal.pone.0153780.
2015
Dokun, A., L. Chen, M. Okutsu, C. Farber, S. Hazarika, W. Jones, D. Craig, D. Marchuk, J. Lye, S. Shan, and B. Annex. 2015. ADAM12: A Genetic Modifier of Pre-clinical Peripheral Arterial Disease. Am J Physiol, DOI: 10.1152/ajpheart.00803.2014.
Zelko, I., and R. Folz. 2015. Regulation of Oxidative Stress in Pulmonary Artery Endothelium: Modulation of EC-SOD and NOX4 Expression Using HDAC Class I Inhibitors. Am J Respir Cell Mol Biol, DOI: 10.1165/rcmb.2014-0260OC.
2013
Chen, Z., T.C. Lai, Y.H. Jan, F.M. Lin, W.C. Wang, H. Xiao, Y.T. Wang, W. Sun, X. Cui, Y.S. Li, T. Fang, H. Zhao, C. Padmanabhan, R. Sun, D.L. Wang, H. Jin, G.Y. Chau, H.D. Huang, M. Hsiao, and J.Y.J. Shyy. 2013. Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. The Journal of Clinical Investigation. 123:1057-1067.
He, M., X. Liang, L. He, W. Wen, S. Zhao, L. Wen, Y. Liu, J.Y.J. Shyy, and Z. Yuan. 2013. Endothelial dysfunction in rheumatoid arthritis: the role of monocyte chemotactic protein-1-induced protein. Arteriosclerosis, Thrombosis, and Vascular Biology. 33:1384-1391.
Yan, Y., X. Li, K. Kover, M. Clements, and P. Ye. 2013. CREB participates in the IGF‐I‐stimulation cyclin D1 transcription. Developmental Neurobiology. 73:559-570.
2012
Jeon, Y.J., M.G. Jo, H.M. Yoo, S.H. Hong, J.M. Park, S.H. Ka, K.H. Oh, J.H. Seol, Y.K. Jung, and C.H. Chung. 2012. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. The Journal of Clinical Investigation. 122:2622-2636.